Description
A glycine-conjugated form of deoxycholic acid; induces a reversible, concentration-dependent reduction in myogenic tone in rats and decreases expression of the gene encoding CYP7A1 in rabbits; serum levels are elevated in non-surviving patients with AALF compared with survivors; plasma levels are increased in the plasma of patients with asthma
Formal name: N-[(3α,5β,12α)-3,12-dihydroxy-24-oxocholan-24-yl]-glycine, monohydrate
Synonyms: GDCA
Molecular weight: 467.6
CAS: 1079043-81-4
Purity: ≥95%
Formulation: A crystalline solid
Product Type|Biochemicals|Lipids|Sterol Lipids||Research Area|Endocrinology & Metabolism|Bile Acids & Microbiome||Research Area|Immunology & Inflammation|Pulmonary Diseases|Asthma